{"id":45044,"date":"2022-06-14T12:01:40","date_gmt":"2022-06-14T10:01:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/"},"modified":"2022-06-14T12:01:40","modified_gmt":"2022-06-14T10:01:40","slug":"general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/","title":{"rendered":"General Anxiety Disorder Therapeutics Global Market Insights Report 2022 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5593618\/general-anxiety-disorder-therapeutics-global?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=h4m53h&amp;utm_campaign=1713001+-+General+Anxiety+Disorder+Therapeutics+Global+Market+Insights+Report+2022&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;General Anxiety Disorder Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220614005571\/en\/1485807\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220614005571\/en\/1485807\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report describes the global market size of General Anxiety Disorder Therapeutics from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its market size to the end of 2027 and its CAGR from 2022 to 2027. For the geography segment, regional supply, demand, major players, price is presented from 2017 to 2027.\n<\/p>\n<p>\nThe key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.\n<\/p>\n<p>\nFor the competitor segment, the report includes global key players of General Anxiety Disorder Therapeutics as well as some small players.\n<\/p>\n<p>\n<strong>The information for each competitor includes:<\/strong>\n<\/p>\n<ul>\n<li>\nCompany Profile\n<\/li>\n<li>\nMain Business Information\n<\/li>\n<li>\nSWOT Analysis\n<\/li>\n<li>\nSales Volume, Revenue, Price and Gross Margin\n<\/li>\n<li>\nMarket Share\n<\/li>\n<\/ul>\n<p>\n<strong>Types Segment:<\/strong>\n<\/p>\n<ul>\n<li>\nItriglumide\n<\/li>\n<li>\nTedatioxetine\n<\/li>\n<li>\nEDG-004\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>Companies Covered:<\/strong>\n<\/p>\n<ul>\n<li>\nBionomics Limited\n<\/li>\n<li>\nEdgemont Pharmaceuticals LLC\n<\/li>\n<\/ul>\n<p>\n<strong>Scope<\/strong>\n<\/p>\n<ul>\n<li>\nBase Year: 2022\n<\/li>\n<li>\nHistorical Data: from 2017 to 2021\n<\/li>\n<li>\nForecast Data: from 2022 to 2027\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>Chapter 1 Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>Chapter 2 Abbreviation and Acronyms<\/strong>\n<\/p>\n<p>\n<strong>Chapter 3 Preface<\/strong>\n<\/p>\n<p>\n3.1 Research Scope\n<\/p>\n<p>\n3.2 Research Sources\n<\/p>\n<p>\n3.2.1 Data Sources\n<\/p>\n<p>\n3.2.2 Assumptions\n<\/p>\n<p>\n3.3 Research Method\n<\/p>\n<p>\n<strong>Chapter 4 Market Landscape<\/strong>\n<\/p>\n<p>\n4.1 Market Overview\n<\/p>\n<p>\n4.2 Classification\/Types\n<\/p>\n<p>\n4.3 Application\/End Users\n<\/p>\n<p>\n<strong>Chapter 5 Market Trend Analysis<\/strong>\n<\/p>\n<p>\n5.1 Introduction\n<\/p>\n<p>\n5.2 Drivers\n<\/p>\n<p>\n5.3 Restraints\n<\/p>\n<p>\n5.4 Opportunities\n<\/p>\n<p>\n5.5 Threats\n<\/p>\n<p>\n5.6 Covid-19 Impact\n<\/p>\n<p>\n<strong>Chapter 6 Industry Chain Analysis<\/strong>\n<\/p>\n<p>\n6.1 Upstream\/Suppliers Analysis\n<\/p>\n<p>\n6.2 General Anxiety Disorder Therapeutics Analysis\n<\/p>\n<p>\n6.2.1 Technology Analysis\n<\/p>\n<p>\n6.2.2 Cost Analysis\n<\/p>\n<p>\n6.2.3 Market Channel Analysis\n<\/p>\n<p>\n6.3 Downstream Buyers\/End Users\n<\/p>\n<p>\n<strong>Chapter 7 Latest Market Dynamics<\/strong>\n<\/p>\n<p>\n7.1 Latest News\n<\/p>\n<p>\n7.2 Merger and Acquisition\n<\/p>\n<p>\n7.3 Planned\/Future Project\n<\/p>\n<p>\n7.4 Policy Dynamics\n<\/p>\n<p>\n<strong>Chapter 8 Trading Analysis<\/strong>\n<\/p>\n<p>\n8.1 Export of General Anxiety Disorder Therapeutics by Region\n<\/p>\n<p>\n8.2 Import of General Anxiety Disorder Therapeutics by Region\n<\/p>\n<p>\n8.3 Balance of Trade\n<\/p>\n<p>\n<strong>Chapter 9 Historical and Forecast General Anxiety Disorder Therapeutics Market in North America (2017-2027)<\/strong>\n<\/p>\n<p>\n9.1 General Anxiety Disorder Therapeutics Market Size\n<\/p>\n<p>\n9.2 General Anxiety Disorder Therapeutics Demand by End Use\n<\/p>\n<p>\n9.3 Competition by Players\/Suppliers\n<\/p>\n<p>\n9.4 Type Segmentation and Price\n<\/p>\n<p>\n9.5 Key Countries Analysis\n<\/p>\n<p>\n<strong>Chapter 10 Historical and Forecast General Anxiety Disorder Therapeutics Market in South America (2017-2027)<\/strong>\n<\/p>\n<p>\n10.1 General Anxiety Disorder Therapeutics Market Size\n<\/p>\n<p>\n10.2 General Anxiety Disorder Therapeutics Demand by End Use\n<\/p>\n<p>\n10.3 Competition by Players\/Suppliers\n<\/p>\n<p>\n10.4 Type Segmentation and Price\n<\/p>\n<p>\n10.5 Key Countries Analysis\n<\/p>\n<p>\n<strong>Chapter 11 Historical and Forecast General Anxiety Disorder Therapeutics Market in Asia &amp; Pacific (2017-2027)<\/strong>\n<\/p>\n<p>\n11.1 General Anxiety Disorder Therapeutics Market Size\n<\/p>\n<p>\n11.2 General Anxiety Disorder Therapeutics Demand by End Use\n<\/p>\n<p>\n11.3 Competition by Players\/Suppliers\n<\/p>\n<p>\n11.4 Type Segmentation and Price\n<\/p>\n<p>\n11.5 Key Countries Analysis\n<\/p>\n<p>\n<strong>Chapter 12 Historical and Forecast General Anxiety Disorder Therapeutics Market in Europe (2017-2027)<\/strong>\n<\/p>\n<p>\n12.1 General Anxiety Disorder Therapeutics Market Size\n<\/p>\n<p>\n12.2 General Anxiety Disorder Therapeutics Demand by End Use\n<\/p>\n<p>\n12.3 Competition by Players\/Suppliers\n<\/p>\n<p>\n12.4 Type Segmentation and Price\n<\/p>\n<p>\n12.5 Key Countries Analysis\n<\/p>\n<p>\n<strong>Chapter 13 Historical and Forecast General Anxiety Disorder Therapeutics Market in MEA (2017-2027)<\/strong>\n<\/p>\n<p>\n13.1 General Anxiety Disorder Therapeutics Market Size\n<\/p>\n<p>\n13.2 General Anxiety Disorder Therapeutics Demand by End Use\n<\/p>\n<p>\n13.3 Competition by Players\/Suppliers\n<\/p>\n<p>\n13.4 Type Segmentation and Price\n<\/p>\n<p>\n13.5 Key Countries Analysis\n<\/p>\n<p>\n<strong>Chapter 14 Summary For Global General Anxiety Disorder Therapeutics Market (2017-2022)<\/strong>\n<\/p>\n<p>\n14.1 General Anxiety Disorder Therapeutics Market Size\n<\/p>\n<p>\n14.2 General Anxiety Disorder Therapeutics Demand by End Use\n<\/p>\n<p>\n14.3 Competition by Players\/Suppliers\n<\/p>\n<p>\n14.4 Type Segmentation and Price\n<\/p>\n<p>\n<strong>Chapter 15 Global General Anxiety Disorder Therapeutics Market Forecast (2022-2027)<\/strong>\n<\/p>\n<p>\n15.1 General Anxiety Disorder Therapeutics Market Size Forecast\n<\/p>\n<p>\n15.2 General Anxiety Disorder Therapeutics Demand Forecast\n<\/p>\n<p>\n15.3 Competition by Players\/Suppliers\n<\/p>\n<p>\n15.4 Type Segmentation and Price Forecast\n<\/p>\n<p>\n<strong>Chapter 16 Analysis of Global Key Vendors<\/strong>\n<\/p>\n<ul>\n<li>\nBionomics Limited\n<\/li>\n<li>\nEdgemont Pharmaceuticals LLC\n<\/li>\n<li>\nH. Lundbeck A\/S\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5593618\/general-anxiety-disorder-therapeutics-global?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=h4m53h&amp;utm_campaign=1713001+-+General+Anxiety+Disorder+Therapeutics+Global+Market+Insights+Report+2022&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/rkdog4<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;&#111;&#x3a;&#x70;&#114;e&#x73;&#115;&#64;&#x72;&#x65;&#115;e&#x61;&#114;c&#x68;&#x61;&#110;d&#x6d;&#97;r&#x6b;&#x65;&#116;s&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">p&#114;&#x65;&#x73;s&#64;&#114;&#x65;&#x73;e&#97;&#x72;&#x63;h&#97;&#110;&#x64;&#x6d;a&#114;&#x6b;&#x65;t&#115;&#46;&#x63;&#x6f;m<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;General Anxiety Disorder Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report describes the global market size of General Anxiety Disorder Therapeutics from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45044","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>General Anxiety Disorder Therapeutics Global Market Insights Report 2022 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"General Anxiety Disorder Therapeutics Global Market Insights Report 2022 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;General Anxiety Disorder Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report describes the global market size of General Anxiety Disorder Therapeutics from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-14T10:01:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220614005571\/en\/1485807\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"General Anxiety Disorder Therapeutics Global Market Insights Report 2022 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-06-14T10:01:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\\\/\"},\"wordCount\":605,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614005571\\\/en\\\/1485807\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\\\/\",\"name\":\"General Anxiety Disorder Therapeutics Global Market Insights Report 2022 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614005571\\\/en\\\/1485807\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-06-14T10:01:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614005571\\\/en\\\/1485807\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614005571\\\/en\\\/1485807\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"General Anxiety Disorder Therapeutics Global Market Insights Report 2022 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"General Anxiety Disorder Therapeutics Global Market Insights Report 2022 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"General Anxiety Disorder Therapeutics Global Market Insights Report 2022 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;General Anxiety Disorder Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report describes the global market size of General Anxiety Disorder Therapeutics from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-14T10:01:40+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220614005571\/en\/1485807\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"General Anxiety Disorder Therapeutics Global Market Insights Report 2022 &#8211; ResearchAndMarkets.com","datePublished":"2022-06-14T10:01:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/"},"wordCount":605,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220614005571\/en\/1485807\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/","name":"General Anxiety Disorder Therapeutics Global Market Insights Report 2022 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220614005571\/en\/1485807\/21\/logo.jpg","datePublished":"2022-06-14T10:01:40+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220614005571\/en\/1485807\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220614005571\/en\/1485807\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/general-anxiety-disorder-therapeutics-global-market-insights-report-2022-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"General Anxiety Disorder Therapeutics Global Market Insights Report 2022 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45044"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45044\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}